You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥(01099.HK)董事長兩會建議推進央企應急醫療物資保障體系支撐作用
阿思達克 03-03 17:10
兩會在即,全國人大代表、國藥控股(01099.HK)董事長於清明接受《上證報》訪問時表示,建議發揮中央企業支撐作用,加快完善醫藥物資儲備聯動機制,推進應急醫藥物資保障體系高水平運行、高質量發展。 於清明建議,推進醫藥物資儲備體系補鏈強鏈。包括建立重點醫藥物資定點生產、集中採購、定點儲備、統一配送、全程追溯的保供平台;建立中央、地方應急醫藥物資調配中心;發揮醫藥央企在全國供應鏈集中調配方面的「主力軍」作用和領先優勢,帶動行業企業積極參與儲備保供工作;建立覆蓋全品類的零售儲備體系,將國有大型零售藥店納入國家醫藥物資儲備定點單位,支持醫藥零售拓展服務新模式。 他又提議建立醫藥物資儲備動態平衡機制。科學編制應急醫藥物資儲備目錄;科學制定儲備數量和方式,以政府為主導、委託大型企業代儲、管理和調運,保持物資儲備的動平衡。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account